CASP3 and Alzheimer disease: The proposed mechanisms of the increase of caspase-3 level in amygdala tissue and KMO production that may contribute to AD’s memory loss symptoms by increasing apoptosis and neuronal loss and decreasing kynurenine metabolite levels were supported by multiple past studies.